• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白激酶 D 信号通路与癌症:是敌是友?

Protein kinase D signaling in cancer: A friend or foe?

机构信息

Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, 200 Lothrop Street, Pittsburgh, PA 15261, USA.

Department of Anesthesiology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China.

出版信息

Biochim Biophys Acta Rev Cancer. 2017 Aug;1868(1):283-294. doi: 10.1016/j.bbcan.2017.05.008. Epub 2017 May 31.

DOI:10.1016/j.bbcan.2017.05.008
PMID:28577984
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5548606/
Abstract

Protein kinase D is a family of evolutionarily conserved serine/threonine kinases that belongs to the Ca/Calmodulin-dependent kinase superfamily. Signal transduction pathways mediated by PKD can be triggered by a variety of stimuli including G protein-coupled receptor agonists, growth factors, hormones, and cellular stresses. The regulatory mechanisms and physiological roles of PKD have been well documented including cell proliferation, survival, migration, angiogenesis, regulation of gene expression, and protein/membrane trafficking. However, its precise roles in disease progression, especially in cancer, remain elusive. A plethora of studies documented the cell- and tissue-specific expressions and functions of PKD in various cancer-associated biological processes, while the causes of the differential effects of PKD have not been thoroughly investigated. In this review, we have discussed the structural-functional properties, activation mechanisms, signaling pathways and physiological functions of PKD in the context of human cancer. Additionally, we have provided a comprehensive review of the reported tumor promoting or tumor suppressive functions of PKD in several major cancer types and discussed the discrepancies that have been raised on PKD as a major regulator of malignant transformation.

摘要

蛋白激酶 D 是一类进化上保守的丝氨酸/苏氨酸激酶,属于钙/钙调蛋白依赖性激酶超家族。PKD 介导的信号转导途径可被多种刺激触发,包括 G 蛋白偶联受体激动剂、生长因子、激素和细胞应激。PKD 的调节机制和生理作用已有详细记录,包括细胞增殖、存活、迁移、血管生成、基因表达调控和蛋白质/膜运输。然而,其在疾病进展中的精确作用,尤其是在癌症中的作用仍不明确。大量研究记录了 PKD 在各种与癌症相关的生物学过程中的细胞和组织特异性表达和功能,而 PKD 产生差异效应的原因尚未得到彻底研究。在这篇综述中,我们讨论了 PKD 在人类癌症中的结构-功能特性、激活机制、信号通路和生理功能。此外,我们还全面回顾了 PKD 在几种主要癌症类型中被报道的促进肿瘤或抑制肿瘤的功能,并讨论了 PKD 作为恶性转化主要调节剂的争议。

相似文献

1
Protein kinase D signaling in cancer: A friend or foe?蛋白激酶 D 信号通路与癌症:是敌是友?
Biochim Biophys Acta Rev Cancer. 2017 Aug;1868(1):283-294. doi: 10.1016/j.bbcan.2017.05.008. Epub 2017 May 31.
2
Evaluating the current status of protein kinase C (PKC)-protein kinase D (PKD) signalling axis as a novel therapeutic target in ovarian cancer.评估蛋白激酶 C(PKC)-蛋白激酶 D(PKD)信号轴作为卵巢癌新型治疗靶点的现状。
Biochim Biophys Acta Rev Cancer. 2021 Jan;1875(1):188496. doi: 10.1016/j.bbcan.2020.188496. Epub 2020 Dec 28.
3
Protein kinase D in vascular biology and angiogenesis.蛋白激酶 D 在血管生物学和血管生成中的作用。
IUBMB Life. 2011 Apr;63(4):258-63. doi: 10.1002/iub.456.
4
Protein kinase D2: a versatile player in cancer biology.蛋白激酶 D2:癌症生物学中的多面手。
Oncogene. 2018 Mar;37(10):1263-1278. doi: 10.1038/s41388-017-0052-8. Epub 2017 Dec 20.
5
Protein kinase D: a new player among the signaling proteins that regulate functions in the nervous system.蛋白激酶 D:一种在调节神经系统功能的信号蛋白中崭露头角的新成员。
Neurosci Bull. 2014 Jun;30(3):497-504. doi: 10.1007/s12264-013-1403-2. Epub 2014 Feb 13.
6
Protein Kinase D: A Potential Therapeutic Target in Prostate Cancer.蛋白激酶D:前列腺癌的一个潜在治疗靶点。
Mol Cell Pharmacol. 2017;9(1):1-4.
7
Protein kinase D signaling: multiple biological functions in health and disease.蛋白激酶 D 信号转导:在健康和疾病中的多种生物学功能。
Physiology (Bethesda). 2011 Feb;26(1):23-33. doi: 10.1152/physiol.00037.2010.
8
Multifaceted Functions of Protein Kinase D in Pathological Processes and Human Diseases.蛋白激酶D在病理过程和人类疾病中的多方面功能
Biomolecules. 2021 Mar 23;11(3):483. doi: 10.3390/biom11030483.
9
Protein kinase D as a potential new target for cancer therapy.蛋白激酶D作为癌症治疗的潜在新靶点。
Biochim Biophys Acta. 2010 Dec;1806(2):183-92. doi: 10.1016/j.bbcan.2010.05.003. Epub 2010 May 24.
10
P2X7 receptors activate protein kinase D and p42/p44 mitogen-activated protein kinase (MAPK) downstream of protein kinase C.P2X7受体在蛋白激酶C下游激活蛋白激酶D和p42/p44丝裂原活化蛋白激酶(MAPK)。
Biochem J. 2002 Sep 15;366(Pt 3):745-55. doi: 10.1042/BJ20020358.

引用本文的文献

1
Targeting adipocyte differentiation with CRT0066101: activation of AMPK signaling in 3T3-L1 cells.用CRT0066101靶向脂肪细胞分化:3T3-L1细胞中AMPK信号通路的激活
Front Pharmacol. 2025 Aug 14;16:1645587. doi: 10.3389/fphar.2025.1645587. eCollection 2025.
2
Effect of PRKD3 on cell cycle in gastric cancer progression and downstream regulatory networks.PRKD3对胃癌进展中细胞周期及下游调控网络的影响。
Med Oncol. 2025 Mar 25;42(5):135. doi: 10.1007/s12032-025-02663-y.
3
Mutant p53-Mediated Tumor Secretome: Bridging Tumor Cells and Stromal Cells.突变型p53介导的肿瘤分泌组:连接肿瘤细胞与基质细胞
Genes (Basel). 2024 Dec 17;15(12):1615. doi: 10.3390/genes15121615.
4
Phosphorylation of Optineurin by protein kinase D regulates Parkin-dependent mitophagy.蛋白激酶D介导的视神经病相关蛋白磷酸化调控帕金蛋白依赖性线粒体自噬。
iScience. 2024 Nov 13;27(12):111384. doi: 10.1016/j.isci.2024.111384. eCollection 2024 Dec 20.
5
Potential Prognostic Role of Protein Kinase D Isoforms in Head and Neck Cancers.蛋白激酶 D 同工型在头颈部癌症中的潜在预后作用。
Int J Mol Sci. 2024 Sep 24;25(19):10274. doi: 10.3390/ijms251910274.
6
Protein kinase D2 modulates hepatic insulin sensitivity in male mice.蛋白激酶 D2 调节雄性小鼠肝脏胰岛素敏感性。
Mol Metab. 2024 Dec;90:102045. doi: 10.1016/j.molmet.2024.102045. Epub 2024 Oct 12.
7
Comparative analysis of the mutational landscape and evolutionary patterns of pancreatic ductal adenocarcinoma metastases in the liver or peritoneum.肝或腹膜中胰腺导管腺癌转移灶的突变图谱和进化模式的比较分析。
Heliyon. 2024 Jul 30;10(15):e35428. doi: 10.1016/j.heliyon.2024.e35428. eCollection 2024 Aug 15.
8
Internalized β2-Adrenergic Receptors Oppose PLC-Dependent Hypertrophic Signaling.β2-肾上腺素能受体内化拮抗 PLC 依赖性肥大信号。
Circ Res. 2024 Jul 5;135(2):e24-e38. doi: 10.1161/CIRCRESAHA.123.323201. Epub 2024 May 30.
9
Structural insights into regulation of the PEAK3 pseudokinase scaffold by 14-3-3.结构洞察 14-3-3 对 PEAK3 假激酶支架的调节作用。
Nat Commun. 2023 Jun 19;14(1):3543. doi: 10.1038/s41467-023-38864-0.
10
Membrane trafficking in breast cancer progression: protein kinase D comes into play.膜运输在乳腺癌进展中的作用:蛋白激酶D发挥作用。
Front Cell Dev Biol. 2023 May 24;11:1173387. doi: 10.3389/fcell.2023.1173387. eCollection 2023.

本文引用的文献

1
Frequent low-level mutations of protein kinase D2 in angiolipoma.血管脂肪瘤中蛋白激酶 D2 的频繁低水平突变。
J Pathol. 2017 Apr;241(5):578-582. doi: 10.1002/path.4865. Epub 2017 Feb 27.
2
Bone Metastasis of Prostate Cancer Can Be Therapeutically Targeted at the TBX2-WNT Signaling Axis.前列腺癌的骨转移可在TBX2-WNT信号轴上进行靶向治疗。
Cancer Res. 2017 Mar 15;77(6):1331-1344. doi: 10.1158/0008-5472.CAN-16-0497. Epub 2017 Jan 20.
3
Kinobead and Single-Shot LC-MS Profiling Identifies Selective PKD Inhibitors.激酶磁珠与单针液相色谱-质谱联用分析鉴定出选择性多囊肾病抑制剂。
J Proteome Res. 2017 Mar 3;16(3):1216-1227. doi: 10.1021/acs.jproteome.6b00817. Epub 2017 Feb 3.
4
A Conditional Knockout Mouse Model Reveals a Critical Role of PKD1 in Osteoblast Differentiation and Bone Development.条件性基因敲除小鼠模型揭示 PKD1 在成骨细胞分化和骨发育中的关键作用。
Sci Rep. 2017 Jan 13;7:40505. doi: 10.1038/srep40505.
5
Androgen suppresses protein kinase D1 expression through fibroblast growth factor receptor substrate 2 in prostate cancer cells.雄激素通过成纤维细胞生长因子受体底物2抑制前列腺癌细胞中蛋白激酶D1的表达。
Oncotarget. 2017 Feb 21;8(8):12800-12811. doi: 10.18632/oncotarget.14536.
6
Genkwadaphnin promotes leukocyte migration by increasing CD44 expression via PKD1/NF-κB signaling pathway.芫花瑞香宁通过PKD1/核因子κB信号通路增加CD44表达来促进白细胞迁移。
Immunol Lett. 2016 May;173:69-76. doi: 10.1016/j.imlet.2016.03.006. Epub 2016 Mar 14.
7
Protein Kinase D Enzymes as Regulators of EMT and Cancer Cell Invasion.蛋白激酶 D 酶作为 EMT 和癌细胞侵袭的调节剂。
J Clin Med. 2016 Feb 3;5(2):20. doi: 10.3390/jcm5020020.
8
Cancer statistics, 2016.癌症统计数据,2016 年。
CA Cancer J Clin. 2016 Jan-Feb;66(1):7-30. doi: 10.3322/caac.21332. Epub 2016 Jan 7.
9
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.识别癌症中的复发性突变揭示了广泛的谱系多样性和突变特异性。
Nat Biotechnol. 2016 Feb;34(2):155-63. doi: 10.1038/nbt.3391. Epub 2015 Nov 30.
10
Lack of PRKD2 and PRKD3 kinase domain somatic mutations in PRKD1 wild-type classic polymorphous low-grade adenocarcinomas of the salivary gland.涎腺PRKD1野生型经典多形性低度腺癌中缺乏PRKD2和PRKD3激酶结构域体细胞突变。
Histopathology. 2016 Jun;68(7):1055-62. doi: 10.1111/his.12883. Epub 2016 Jan 4.